Evidence map›Paper›PMID 40184450›Full record

ArticleScience advances2025

Mg

Kotaro Hirano, Chika Nakabayashi, Mao Sasaki, Miki Suzuki, Yuta Aoyagi, Kaori Tanaka, Akira Murakami, Masaki Tsuchiya, Eiji Umemoto, Shuji Takabayashi and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Kotaro HiranoSchool of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.ORCID 0009-0009-8936-7645
Chika NakabayashiSchool of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
Mao SasakiSchool of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
Miki SuzukiSchool of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
Yuta AoyagiSchool of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
Kaori TanakaDepartment of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Akira MurakamiSchool of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
Masaki TsuchiyaSchool of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
Eiji UmemotoSchool of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.
Shuji TakabayashiInstitute of Photonics Medicine, Hamamatsu University School of Medicine, Shizuoka 431-3192, Japan.ORCID 0000-0001-9268-3782
Yasuo KitajimaDepartment of Immunology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan.ORCID 0000-0001-6277-5918
Yusuke OnoDepartment of Muscle Development and Regeneration, Institute of Molecular Embryology and Genetics, Kumamoto University, Kumamoto 860-0811, Japan.ORCID 0000-0002-4802-7507
Takehisa MatsukawaFaculty of Pharmacy, Laboratory of Hygienic Chemistry, Juntendo University, Chiba 279-0013, Japan.ORCID 0000-0002-5667-1589
Masayuki MatsushitaDepartment of Molecular and Cellular Physiology, Graduate School of Medicine, University of the Ryukyus, Okinawa 903-0213, Japan.
Yasuyuki OhkawaDepartment of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.ORCID 0000-0001-6440-9954
Yasuo MoriDepartment of Synthetic Chemistry and Biological Chemistry, Graduate School of Engineering, Kyoto University, Kyoto 615-8510, Japan.ORCID 0000-0001-7180-1938
Yuji HaraSchool of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan.ORCID 0000-0003-0021-1740

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Muscle satellite cells (MuSCs) respond immediately to environmental cues upon skeletal muscle injuries. Despite decades of research into muscle regeneration, the specific molecular factors that trigger the transition of MuSCs from a quiescent to an active state remain largely unidentified. Here, we identify transient receptor potential melastatin 7 (TRPM7), an Mg

Indexed as

MagnesiumSatellite Cells, Skeletal MuscleTRPM Cation ChannelsAnimalsMiceMice, KnockoutMuscle, SkeletalRegenerationSignal TransductionTOR Serine-Threonine KinasesMagnesiumTOR Serine-Threonine KinasesTrpm7 protein, mouseTRPM Cation Channels

Identifiers

PMID40184450
PMCPMC11970462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.